Protective role of vitamin D3 in a rat model of hyperthyroid-induced cardiomyopathy

10.1016/j.jtcme.2023.02.007

Heba Rady Salem；Ghada Adel Hegazy；Rania Abdallah；Reda AA. Abo-Elsoud

Caspase-3 ； FGF23 ； Heart ； Hyperthyroidism ； Oxidative stress ； PCNA ； Rat ； Vitamin D

Journal of Traditional and Complementary Medicine

13卷3期（2023 / 05 / 01）

277 - 284

英文

Background and aim: Several studies have reported the cardioprotective effect of vitamin D. Thus, this study aimed to investigate the possible cardioprotective effect of vitamin D3 in hyperthyroid-induced cardiomyopathy rat model. Experimental procedure: Rats were divided into 3 groups: control group; hyperthyroid group, rats were administrated L-thyroxine sodium daily for 4 weeks; and hyperthyroid + vitamin D3 treated group, rats were treated with L-thyroxine sodium for 4 weeks daily, and received the vitamin D3 for the same duration. After 4 weeks, electrocardiogram (ECG) was recorded. Then, blood samples were collected for biochemical analysis. After that, the final body weight was measured, and the rats were sacrificed. Finally, the hearts were excised, weighed and were prepared for histological examination by hematoxylin and eosin, and immunohistochemistry assessment of caspase-3 and proliferating cell nuclear antigen(PCNA).Results: Hyperthyroid rats showed significant ECG changes, increased serum levels of cardiac biomarkers, fibroblast growth factor-23 (FGF23), malondialdehyde, antioxidant enzymes, tumor necrosis factor-alpha (TNF-α) and relative heart weight compared with the control rats. Vitamin D3 coadminis-tration with L-thyroxine resulted in significant improvement in thyroid profile, ECG parameters, significant decrease of cardiac biomarkers, FGF23, malondialdehyde, TNF-α and relative heart weight, and significant decrease of the antioxidant enzymes compared with the hyperthyroid rats. The histological study was consistent with the biochemical results. Hyperthyroid rats showed upregulation of caspase-3and PCNA in the myocardium compared with control group. Vitamin D3 treated rats showed down-regulation of caspase-3 and PCNA. Conclusion: Vitamin D3 provides cardioprotective effects in hyperthyroid rats.

1. Bae, S,Singh, SS,Yu, H(1985).Vitamin D signaling pathway plays an important role in the development of heart failure after myocardial infarction.J Appl Physiol,114(8),979-987.
2. Bancroft, JD,Gamble, M.(2008).Theory and Practice of Histological Techniques.Elsevier health sciences.
3. Berg, J,Sandvik, J,Ree, AH(1994).1, 25-Dihydroxyvitamin D3 attenuates adenylyl cyclase activity in rat thyroid cells: reduction of thyrotropin receptor number and increase in guanine nucleotide-binding protein Gi-2 alpha.Endocrinology,135(2),595-602.
4. Bielecka-Dabrowa, A,Mikhailidis, DP,Rysz, J(2009).The mechanisms of atrial fibrillation in hyperthyroidism.Thyroid Res,2(1),1-7.
5. Bodey, B,Bodey, V,Siegel, SE(2004).Immunocytochemical detection of members of the caspase cascade of apoptosis in high-grade astrocytomas.In vivo,18(5),593-602.
6. Chainy, GB,Sahoo, DK(2020).Hormones and oxidative stress: an overview.Free Radic Res,54(1),1-26.
7. Chen, S,Law, CS,Grigsby, CL(2011).Cardiomyocyte-specific deletion of the vitamin D receptor gene results in cardiac hypertrophy.Circulation,124(17),1838-1847.
8. Christakos, S,Hewison, M,Gardner, DG(2013).Vitamin D: beyond bone.Ann N Y Acad Sci,1287(1),45.
9. Costilla, M,Macri Delbono, R,Klecha, A(2019).Oxidative stress produced by hyperthyroidism status induces the antioxidant enzyme transcription through the activation of the Nrf-2 factor in lymphoid tissues of Balb/c mice.Oxid Med Cell Longe,2019
10. El Agaty, SM(2019).Cardioprotective effect of vitamin D2 on isoproterenol-induced myocardial infarction in diabetic rats.Arch Physiol Biochem,125(3),210-219.
11. Erben, RG(2018).Physiological actions of fibroblast growth factor-23.Mini review. Front Endocrinol,267,9.
12. Fadel, BM,Ellahham, S,Lindsay, Jr, J(2000).Hyperthyroid heart disease.Clin Cardiol,23(6),402-408.
13. Fagundes, GE,Macan, TP,Rohr, P(2019).Vitamin D3 as adjuvant in the treatment of type 2 diabetes mellitus: modulation of genomic and biochemical instability.Mutagenesis,34(2),135-145.
14. Ferrari, SM,Ruffilli, I,Elia, G(2019).Chemokines in hyperthyroidism.J Clin Transl Endocrinol,16,100196.
15. Gardner, DG,Chen, S,Glenn, DJ(2013).Vitamin D and the heart.Am J Physiol Regul Integr Comp Physiol,305(9),R969-R977.
16. Grais, IM,Sowers, JR(2014).Thyroid and the heart.Am J Med.,127(8),691-698.
17. Gül, SS,Aygün, H.(2018).Cardioprotective effect of vitamin D and melatonin on doxorubicin-induced cardiotoxicity in rat model: an electrocardiographic, scintigraphic and biochemical study.Eur Respir J.,120(4),249-255.
18. Guler, G,Dasdelen, D,Baltaci, SB(2022).The effects of thyroid dysfunction on DNA damage and apoptosis in liver and heart tissues of rats.Horm Mol Biol Clin Invest,43(1),47-53.
19. Han, S-x,Bai, E,Jin, G-h(2014).Expression and clinical significance of YAP, TAZ, and AREG in hepatocellular carcinoma.J Immunol Res,2014
20. Ibrahim, RYM,Saber, AA,Hammad, HBI(2021).The possible role of the seaweed Ulva fasciata on ameliorating hyperthyroidism-associated heart inflammations in a rat model.Environ Sci Pollut Res,28(6),6830-6842.
21. Jabbar, A,Pingitore, A,Pearce, SHS(2017).Thyroid hormones and cardiovascular disease.Nat Rev Cardiol,14(1),39-55.
22. Kaplan, S,Türk, A,Aydın, H(2021).Vitamin D improves oxidative stress and histopathological damage in rat ovaries caused by hyperthyroidism.J Obstet Gynaecol Res.,47(10),3551-3560.
23. Kim, M,Lee, B-C(2019).Therapeutic effect of scutellaria baicalensis on L-thyroxine-induced hyperthyroidism rats.Evid Based Complement Alternat Med,2019,3239649.
24. Klein, I,Ojamaa, K(2001).Thyroid hormone and the cardiovascular system.N Engl J Med.,344(7),501-509.
25. Kumar, P,Srivastava, P,Gupta, A(2017).Noninvasive recording of electrocardiogram in conscious rat: a new device.Indian J Pharmacol,49(1),116.
26. Lu, EM,Ratnayake, J,Rich, AM(2019).Assessment of proliferating cell nuclear antigen (PCNA) expression at the invading front of oral squamous cell carcinoma.BMC Oral Health. Oct,19(1),233.
27. Makay, B,Makay, O,Yenisey, C(2009).The interaction of oxidative stress response with cytokines in the thyrotoxic rat: is there a link?.Mediat Inflamm,2009
28. Martineau, AR,Thummel, KE,Wang, Z(2019).Differential effects of oral boluses of vitamin D2 vs vitamin D3 on vitamin D metabolism: a randomized controlled trial.J Clin Endocrinol Metab,104(12),5831-5839.
29. Mayyas, F,Alsaheb, A,Alzoubi, K(2019).The role of fish oil in attenuating cardiac oxidative stress, inflammation and fibrosis in rat model of thyrotoxicosis.Heliyon,5(12),e02976.
30. Mogulkoc, R,Baltaci, AK,Oztekin, E(2006).Effects of hyperthyroidism induced by L-thyroxin administration on lipid peroxidation in various rat tissues.Acta Biol Hung,57(2),157-163.
31. Mohammed, NA,El-Malkey, NF,Ibrahim, AA-s(2019).Vitamin D3 supplementation ameliorates ovariectomy-induced cardiac apoptotic and structural changes in adult albino rats.Can J Physiol Pharmacol,97(7),647-654.
32. Mousa, A,Misso, M,Teede, H(2016).Effect of vitamin D supplementation on inflammation: protocol for a systematic review.BMJ Open,6(4),e010804.
33. Oktay, S,Uslu, L,Emekli, N(2017).Effects of altered thyroid states on oxidative stress parameters in rats.J Basic Clin Physiol Pharmacol,28(2),159-165.
34. Oliveros-Ruiz, L,Vallejo, M,Diez Canseco, LF(2013).Determinants of thyrotoxic cardiomyopathy recovery.BioMed Res Int,2013,452709.
35. Osuna, PM,Udovcic, M,Sharma, MD(2017).Hyperthyroidism and the heart.Methodist Debakey Cardiovasc,13(2),60.
36. Park, SE,Cho, MA,Kim, SH(2007).The adaptation and relationship of FGF-23 to changes in mineral metabolism in Graves' disease.Clin Endocrinol,66(6),854-858.
37. Razvi, S,Jabbar, A,Pingitore, A(2018).Thyroid hormones and cardiovascular function and diseases.J Am Coll Cardiol,71(16),1781-1796.
38. Rowida, RI,Eman, S,Salwa, MA(2019).Effect of Vitamin D on Serum Fibroblast Growth Factor-23 and Cardiac Tissue Hydroxyproline Levels in Experimentally Induced Insulin Resistance Associated with Left Ventricular Hypertrophy in Rats.Med J Cairo Univ,87,1731-1740.
39. Rowisha, MA,Abou-Koura, HG,AL-Hourany, HA-S(2019).Effect of Vitamin D3 (Cholecalciferol) Administration as an Adjuvant Therapy in Preterm Neonates with Respiratory Distress Syndrome. vol. 87.The Medical Journal of Cairo University,87,693-703.
40. Safari, F,Fazeli, M,Dehghani, M(2015).1, 25 Dihydroxyvitamin D3 protects the heart against pressure overload-induced hypertrophy without affecting SIRT1 mRNA level.Int J Med,2(3),208-217.
41. Saw, RP,Armstrong, BK,Mason, RS(2014).Adjuvant therapy with high dose vitamin D following primary treatment of melanoma at high risk of recurrence: a placebo controlled randomised phase II trial (ANZMTG 02.09 Mel-D).BMC Cancer,14(1),1-10.
42. Schleithoff, SS,Zittermann, A,Tenderich, G(2006).Vitamin D supplementation improves cytokine profiles in patients with congestive heart failure: a double-blind, randomized, placebo-controlled trial.Am J Clin Nutr,83(4),754-759.
43. Shakoor, SAKKA,Jiao, HL,Tan, AWK(2021).The role of inflammation in contributing to vascular risk in subclinical hyperthyroidism: randomized controlled trial.J Endocrinol Metab,11(1),28-32.
44. Shimada, T,Hasegawa, H,Yamazaki, Y(2004).FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis.J Bone Miner Res.,19(3),429-435.
45. Singh, Z,Karthigesu, IP,Singh, P(2014).Use of malondialdehyde as a biomarker for assessing oxidative stress in different disease pathologies: a review.Iran J Public Health,43(Supple 3),7-16.
46. Siu, C-W,Yeung, C-Y,Lau, C-P(2007).Incidence, clinical characteristics and outcome of congestive heart failure as the initial presentation in patients with primary hyperthyroidism.Heart,93(4),483-487.
47. Tousson, E,Hafez, E,Massoud, AA(2013).Protective role of folic acid in thyrox-ineinduced cardiac hypertrophy in hyperthyroid rat.Biomed Aging Pathol,3(2),89-95.
48. Wiseman, H(1993).Vitamin D is a membrane antioxidant Ability to inhibit iron-dependent lipid peroxidation in liposomes compared to cholesterol, ergosterol and tamoxifen and relevance to anticancer action.FEBS Lett,326(1-3),285-288.
49. Zeng, X,Yu, X,Xiao, S(2017).Effects of 1,25-dihydroxyvitamin D3 on pathological changes in rats with diabetic cardiomyopathy.Lipids Health Dis,16(1),109.
50. Zhang, Y,Dedkov, EI,Teplitsky, D(2013).Both hypothyroidism and hyperthyroidism increase atrial fibrillation inducibility in rats.Circ Arrhythm Electrophysiol,6(5),952-959.